| Literature DB >> 11179541 |
M L Wolfe1, S F Vartanian, J L Ross, L L Bansavich, E R Mohler, E Meagher, C A Friedrich, D J Rader.
Abstract
Niaspan, when added to a stable dose of a statin in 66 subjects, was found to be safe and highly effective in improving lipid parameters. Subgroup analyses demonstrated its effectiveness in lowering low-density lipoprotein cholesterol in persons not at the National Cholesterol and Education Program low-density lipoprotein cholesterol target and in raising high-density lipoprotein cholesterol in persons with levels < 40 mg/dl.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11179541 DOI： 10.1016/s0002-9149(00)01410-7
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778